Biodesix (BDSX) Net Cash Flow Growth (1y) (2020 - 2026)
Biodesix (BDSX) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 84.25% |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | 176.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176.20% |
| Dec 31, 2025 | 146.17% |
| Sep 30, 2025 | 61.86% |
| Jun 30, 2025 | -89.83% |
| Mar 31, 2025 | 41.58% |
| Dec 31, 2024 | -180.09% |
| Sep 30, 2024 | -544.80% |
| Jun 30, 2024 | 490.69% |
| Mar 31, 2024 | 16.95% |
| Dec 31, 2023 | -76.91% |
| Sep 30, 2023 | 118.13% |
| Jun 30, 2023 | -164.68% |
| Mar 31, 2023 | -9.38% |
| Dec 31, 2022 | 283.63% |
| Sep 30, 2022 | -58.97% |
| Jun 30, 2022 | 1,092.06% |
| Mar 31, 2022 | -136.32% |
| Dec 31, 2021 | -127.25% |
| Sep 30, 2021 | -58.36% |
| Jun 30, 2021 | -79.17% |